Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Pharmacogenetics of human cytosolic sulfotransferases

Nowell, S, Falany, C N · 2006 · Oncogene

Abstract

Cytosolic sulfotransferases (SULTs) are phase II detoxification enzymes that are involved in the biotransformation of a wide variety of structurally diverse endo- and xenobiotics, including many therapeutic agents and endogenous steroids. Single-nucleotide polymorphisms (SNPs) in SULTs have functional consequences on the translated protein. For the most part, these SNPs are fairly uncommon in the population, but some, most notably for SULT isoform 1A1, are commonly found and have been associated with cancer risk for a variety of tumor sites and also with response to therapeutic agents. SNPs in the hydroxysteroid sulfotransferase, SULT2A1, have been identified in African-American subjects and influence the ratio of plasma DHEA:DHEA-S. This modification could potentially influence cancer risk in steroidogenic tissues. SNPs in many SULTs are ethnically distributed, another factor that could influence SULT pharmacogenetics. Finally, genetic variation has also been identified in 3'-phosphoadenoside 5'-phosphosulfate synthetase (PAPPS), the enzymes responsible for producing the obligatory cosubstrate for all sulfotransferases. Taken together, this variability could substantially influence the disposition of drugs metabolized by SULTs. Elucidation of the basis and effect of variability in sulfation could greatly impact individualized therapy in the future.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209376

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 2

  1. Falany CN, Wheeler J, Oh TS, Falany JL . (1994b). J Steroid Biochem Mol Biol 48: 369–375. · DOI · Paper page
  2. Wilborn T, Lang N, Smith M, Meleth S, Falany C . (2005). J Steroid Biochem Mol Biol, in press.

Cited by

See all 162

Metadata

Authors
Nowell, S., & Falany, C. N.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • University of Alabama at Birmingham (US)
Corresponding author
  • Nowell, S
  • Falany, C N
Venue
Oncogene
Published
2006-03-13
Volume
25
Issue
11
Pages
1673-1678
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2058380077
Cited by
158
References
49
Citations by year
2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 11 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 15
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
cytosolic sulfotransferases, SULT1A1, SULT2A1, hydroxysteroid sulfotransferase, single nucleotide polymorphisms, genetic variation, cancer risk, drug metabolism, sulfation, 3'-phosphoadenosine 5'-phosphosulfate, personalized treatment, phase II enzymes
MeSH terms
Antineoplastic Agents, Black or African American, Ethnicity, Humans, Isoenzymes, Neoplasms, Pharmacogenetics, Sulfotransferases, Arylsulfotransferase, Xenobiotics, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacogenetics of human cytosolic sulfotransferases. https://app.cochat.ai/papers/10.1038/sj.onc.1209376
The paper
Nowell, S., & Falany, C. N. (2006). Pharmacogenetics of human cytosolic sulfotransferases. Oncogene. https://doi.org/10.1038/sj.onc.1209376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.